Highlights d Mechanical forces have an essential function in promoting AT1 cell differentiation d A cell protrusion process occurs at the basal side of the distal airway epithelium d FGF10-mediated ERK1/2 signaling is essential for the cell protrusion process d Cell protrusion process protects against mechanical force for AT2 cell fate
In Brief
Li et al. demonstrated that mechanical forces and local growth factors synergistically control embryonic lung alveolar epithelial cell differentiation. Mechanical force from amniotic fluid inhalation ensures AT1 cell differentiation, whereas FGF10-mediated ERK1/2 signaling induces a protrusive structure in some cells that protects from mechanical force-caused flattening to specify AT2 fate. 
INTRODUCTION
The mammalian lung is essential for gas exchange between blood and the outside environment. In embryos, the lung develops from epithelial tubes that branch into a complex branching network. At late embryonic stages, the distal airway tubules begin to dilate to form thin-walled distal sacs; this dilation starts at 24 weeks in humans and at embryonic day 16.5 (E16.5) in mice (Morrisey and Hogan, 2010; Smith et al., 2010) . During distal sac formation, alveolar progenitor cells in distal airways subsequently differentiate into alveolar type I (AT1) epithelial cells or alveolar type II (AT2) epithelial cells Morrisey and Hogan, 2010; Nikolic et al., 2017; Rawlins et al., 2009 ). AT1 cells are thin and flat in shape, and function mainly in gas exchange via their close contact with vascular endothelial cells. AT2 cells, in contrast, are cuboidal in shape. There are two primary functions of AT2 cells: they produce pulmonary surfactant and they are alveolar stem cells in adult lungs. Given that these alveolar epithelial cells are essential for lung gas exchange post birth, any disruption of alveolar epithelium development results in neonatal death or in serious neonatal diseases that can affect lung function into adulthood, for example in bronchopulmonary dysplasia (Kwinta and Pietrzyk, 2010; Lum et al., 2011) .
Despite the vital importance of distal sac formation and alveolar epithelial cell differentiation for the essential lung function, we know very little about the cellular and molecular mechanisms that drive the spatially and temporally controlled developmental process of lungs. Genetic studies have shown that signals mediated by glucocorticoids, retinoic acid, fibroblast growth factor (FGF), parathyroid hormone, leukemia inhibitory factor, insulinlike growth factor 1, and histone deacetylase 3 (Hdac3) are involved in this process (Alanis et al., 2014; Chang et al., 2013; El Agha et al., 2014; Epaud et al., 2012; Moreno-Barriuso et al., 2006; Ramirez et al., 2000; Wang et al., 2016) . It is also suspected that some unknown intercellular interactions between blood vessels and epithelial cells may contribute to distal sac formation (Yang et al., 2016) .
Both clinical studies and anatomical research from as long as 40 years ago reported that fetal breathing movements and the inhalation of amniotic fluid appear to be important for late lung development (Cock and Harding, 1997; Liggins et al., 1981; Moessinger et al., 1990; Wigglesworth and Desai, 1982) . Blocking fetal breathing movements or prolonged leakage of amniotic fluid causes pulmonary hypoplasia, which frequently results in high morbidity and mortality (Perlman et al., 1976; Sandler et al., 1994; Tseng et al., 2000) . Other early studies showed that mechanical forces generated by fetal breathing movements affect lung development (Harding, 1997; Kitterman, 1996; Liu and Post, 2000) . Thus, at a minimum, any study of late lung development must consider the influence of both mechanical forces and genetic programs.
At the start of E16.5 in mice, distal airways are still lumenclosed epithelial tubules and contain tip epithelial cells that can be lineage labeled using an Id2-CreER knockin allele (Rawlins et al., 2009; Morrisey and Hogan, 2010) . Id2 (inhibitor of DNA binding 2) encodes a transcription factor that is highly expressed in tip epithelial cells. It has been shown that these Id2 + tip epithelial cells contain alveolar progenitor cells that can give rise to AT1 and AT2 cells (Rawlins et al., 2009 ). Differentiation of these tip cells begins soon after E16.5, and proceeds in a proximal-todistal manner over a 2-day period from E16.5 to E18. 5 .5, amniotic fluid was aspirated from yolk sacs of embryos, a treatment called oligoamnios. Lungs from oligoamnios-treated embryos (B) and their non-treated littermate embryos (A) were sampled at E18.5. Lung sections were stained for antibodies against Ager (green), Pdpn (white), and Prospc (red). (C) The distance of neighboring AT1 cells was quantified in lungs of non-treated littermates and oligoamnios-treated embryos (data are presented as mean ± SEM, n = 3). (D) At E18.5, the ratio of AT2 cells to AT1 cells increased significantly in oligoamnios-treated embryos compared with their non-treated littermate embryos (data are presented as mean ± SEM, n = 3). In all examined lungs, alveolar progenitor cells (i.e., those cells expressing markers of both AT1 cells and AT2 cells) accounted for fewer than 5% of alveolar epithelial cells. S1A-S1C 0 ). Considering both the rapidity of distal sac formation and the complex biophysical and biochemical environment of the developing lung, an ability to monitor cellular processes in real time could provide important insights about the mechanisms that control this highly dynamic developmental process. Therefore, we here established live imaging approaches in combination with lineage-tracing tools that enabled us to continuously monitor the changes in the differentiation of alveolar progenitor cells during distal sac formation. Using mouse genetics, in vivo and ex vivo live imaging, and quantitative cell biology, we investigated the cellular mechanisms and genetic programs that control alveolar epithelial cell differentiation. We found that the mechanical forces generated by inhalation of amniotic fluid are essential for AT1 cell differentiation. We show that some alveolar progenitor cells undergo an actin-based cell protrusion process toward the mesenchyme in an FGF10/FGFR2-dependent manner. The cell protrusion process results in reduced apical surface area and accumulation of apical myosin in protruded cells and prevents them from being flattened by mechanical forces, thereby ensuring their AT2 cell fate. Our study demonstrated a sophisticated developmental process whereby cell differentiation is coordinated by both mechanical forces and local growth factor.
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RESULTS
Mechanical Forces Have an Essential Function in Promoting Alveolar Progenitor Cell Flattening and AT1 Cell Differentiation
Anatomical and clinical studies of lung development have shown that both distal sac formation and epithelial cell flattening occur alongside inhalation of amniotic fluid into distal airways (Buckley et al., 2005) . It has been shown that prolonged leakage of amniotic fluid causes neonatal pulmonary hypoplasia (Perlman et al., 1976) . These observations suggest that one essential function of fetal breathing movements is to regulate both distal sac formation and alveolar epithelial cell flattening. Although fetal breathing movements can be observed in mouse embryos as early as E14.5 (Abadie et al., 2000) , our group and others have not observed inhalation of amniotic fluid into distal airways prior to E16.5 (Figures S2A-S2C) (Buckley et al., 2005) . To investigate the role of the inhalation of amniotic fluid in alveolar epithelial cell fate specification, we aspirated the great majority of the amniotic fluid from the yolk sacs of E15.5 embryos, an experimental technique known as oligoamnios. Oligoamnios-treated embryos and non-treated littermate embryos were sampled at E18.5. Unsurprisingly, both terminal sac opening and cell shape flattening of AT1 cells were greatly impaired by oligoamnios treatment at E18.5 ( Figures 1A-1C ). We analyzed the epithelial cell differentiation by immunostaining against AT1 cell and AT2 cell markers.
Due to the thin and large cell shape of AT1 cells, it is difficult to quantify the number of AT1 cells using a single AT1 cell marker, so we used two AT1 cell markers-podoplanin (Pdpn) and advanced glycosylation end product-specific receptor (Ager)to label both the apical and basal sides of AT1 cells. A single AT2 cell marker, surfactant-associated protein C (Prospc), was adequate to allow the quantification of the number of AT2 cells. Immunostaining results showed that the ratio of AT2 cells to AT1 cells among all alveolar epithelial cells increased significantly in the oligoamnios-treated embryos compared with non-treated littermate embryos ( Figures 1A, 1B , 1D, and S2D); Real-time qPCR results analysis also showed that the expression of Pdpn decreased and the expression of Sftpc increased in the oligoamnios-treated lungs (Figures 1E and 1F) .
It has been proposed that the inhalation of amniotic fluid functions to exert mechanical forces on the distal airway epithelium (Harding, 1997; Kitterman, 1996; Liu and Post, 2000) . We set up an equibiaxial strain cell culture system to evaluate the influence of mechanical forces by culturing Id2 + epithelial cells (isolated from E16.5 lungs) on silicone membranes (Figures 1G and S2E) (Liu et al., 2016) . It was shown that distal tip epithelium comprises a population of alveolar progenitor cells, which are Id2 + epithelial cells and can give rise to both AT1 and AT2 cells (Figures S2F and S2G) (Rawlins et al., 2009) . The cells that were not stretched showed Prospc expression but little Pdpn expression, whereas cells that were stretched had only minimal Prospc expression but high Pdpn expression ( Figure 1G ). Identical trends were observed for the expression of Pdpn and Sftpc mRNA in non-stretched and stretched cells (Figures 1H and 1I) . We also cultured Id2 + alveolar progenitor cells for 3 days on gels of differing stiffness ( Figure S2I ). The stiffness of gels implies the elastic modulus of gels, which is measured in pascals (Pa). The mechanical response of cells is stronger when the stiffness of gels increases. By day 3, all cells that were cultured on the low-stiffness (0.4 kPa) gels appeared to be AT2 cells whereas cells cultured on the high-stiffness (4.0 kPa) gels all appeared to be AT1 cells ( Figures S2I-S2K ). Our cell-stretching and gel-stiffness cell differentiation experiments demonstrate that strength of mechanical forces applied to alveolar progenitor cells differentially regulates AT1 versus AT2 cell differentiation, and that mechanical forces are essential to promote alveolar progenitor cell flattening and AT1 cell differentiation.
Investigating Distal Sac Formation with In Vivo and Ex Vivo Live Imaging Systems
Our results demonstrated that the strength of mechanical forces regulates the differentiation of alveolar progenitor cells. Flattened AT1 cells and cuboidal AT2 cells are adjacent to each other in E18.5 lungs ( Figure S1D ), a situation that raises a question of how some of the alveolar progenitor cells are able to (E and F) The mRNA levels of Pdpn and Sftpc in lungs of oligoamnios-treated embryos and in lungs of non-treated littermate embryos were measured by real-time qPCR (data are presented as mean ± SEM, n = 3). (G) Pregnant females carrying Id2-CreER;Rosa26-mTmG embryos were treated with tamoxifen at E15.5, and GFP + cells were selected by fluorescence-activated cell sorting (FACS) at E16.5. The Id2 + progenitor cells isolated from E16.5 embryos had been cultured using an equibiaxial strain cell culture system. Cells were immunostained with antibodies against Prospc (green) and Pdpn (white). (H and I) The mRNA levels of Pdpn and Sftpc in Id2 + progenitor cells and Id2 + progenitor cells that were cultured on silicon membranes were measured by realtime qPCR (data are presented as mean ± SEM, n = 3). AP, alveolar progenitor cells. *p < 0.05, **p < 0.01, ***p < 0.001, Student's t test. Scale bars, 50 mm (A and B) and 10 mm (G). See also Figures S1 and S2. maintain their cuboidal shape and not be flattened by the mechanical forces generated from the inhalation of amniotic fluid. To investigate the cellular processes involved in the cell fate specification of alveolar progenitor cells, we adapted a timelapse imaging system to image developing lungs in living mouse embryos (Figures S3A and S3A 0 ) ( Looney et al., 2011) .
In these experiments, live embryos (E16.5) were removed from the mother's abdominal cavity but were still connected to the maternal circulatory system ( Figures S3B, S3C , and S3C 0 ). The embryonic lungs were held gently with a vacuum imaging device during the image capture period to manage destabilizing interference from heartbeats and fetal breathing movements (Figures S3D and S3D 0 ; Movies S1 and S2). This experimental system enables imaging of lungs for 3 hr prior to the appearance of any signs of edema or hemorrhage.
To facilitate monitoring of lung development over a longer time frame, we established an additional ex vivo system to image the cellular processes that occur during distal sac formation. Embryonic lung explants could be imaged over a period of 10 hr using this ex vivo system. The lung explant retained an intact connection with the heart so that both oxygen and nutritional media could be pumped through the right heart ventricle into the pulmonary circulation system ( Figures S3E and S3F ). Even after 10 hr of imaging, the pulmonary vessels of explant lungs were still intact and did not exhibit any leakage of an indicator dye (200KD FITC-dextran) ( Figure S3G ). When we imaged epithelial cell proliferation in lung explants (E16.5) from Shh-Cre;Rosa26-tTA;tetO-H2BGFP mice, we observed the airway-tip-specific proliferation that is characteristic of normal developing lungs (Movie S3).
An Actin-Based Cell Protrusion Process Occurs at the Basal Side of the Distal Airway Epithelium It is well established that distal airway dilation starts around E16.5. To explore the cellular processes associated with this dilation, we imaged lung explants of E16.5 Shh-Cre;Rosa26-mTmG mouse embryos. Interestingly, we observed that many epithelial cells were protruding from the basal side of airway epithelia in these mice. In the initial stage of the protrusion process, the basal side of protruding cells had thin membrane projections facing the mesenchyme. Within 30 min this cell membrane projection began to elongate, and the cell body gradually started to protrude from the distal airway epithelium (Figure 2A and Movie S4) . Although this cellular protrusion process was widely observable in lung explants at E16.5, it was only observable in distal regions by E17.5 and was detected only rarely in E18.5 lungs. Additionally, no protruding cells underwent cell division after they initiated their protrusion process (n = 2,052 cells).
Given that the cellular processes observed in our ex vivo lung explants may not fully recapitulate what happens in vivo, we also examined the cell protrusion process in live embryos and consistently observed many epithelial cells at variously advanced stages of the cell protrusion process, from barely visible thin membrane projections all the way through to fully protruded cell bodies extending out of the airway epithelium (Figures 2B-2B 0000 ). A series of images of one particular cell membrane projection taken once every 5 min over a 45-min period shows the obvious morphological changes that occur during the cell protrusion process ( Figure 2C and Movie S5). These dynamic changes suggest the action of microtubules, actin, or some other cellular motility mechanism. By phalloidin staining, we found actin filaments in the projection structure ( Figure S3H ). We further treated E16.5 lung explants with inhibitors that can block actin polymerization, actin filament branching, microtubule assembly, or myosin activity. Cytochalasin D (CytoD) is an inhibitor of actin polymerization (Casella et al., 1981) . CK666 selectively inhibits actin assembly mediated by the actin-related protein Arp2/3 complex, which is required for the formation and elongation of daughter actin filament branches (Hetrick et al., 2013) . Nocodazole specifically blocks the polymerization of microtubules (Beswick et al., 2006) . Blebbistatin specifically inhibits myosin II ATPase activity (Kovacs et al., 2004) . We found that both CytoD and CK666, but not nocodazole or blebbistatin, significantly blocked both the emergence of membrane projections and the cell body protrusion process ( Figure 2D ), demonstrating that this cell protrusion process is an actin-based cellular process.
FGF10-Mediated ERK1/2 Signaling Is Essential for the Cell Protrusion Process
Actin-based cell migration usually proceeds toward an external chemical attractant (Wang, 2009) . We therefore investigated the molecular genetic signaling network underlying the cell protrusion process. We propose that some localized chemotactic factors secreted from the distal mesenchyme function to drive the directional protrusion of alveolar progenitor cells. Fgf10, which is preferentially expressed in the mesenchyme, is known to be essential for airway branching morphogenesis (Bellusci et al., 1997) . FGF10 binds to FGFR2, its receptor in the airway epithelium, to activate the downstream ERK1/2 signaling that is essential for the proliferation and migration of airway epithelial cells (Abler et al., 2009; Bellusci et al., 1997; Park et al., 1998) . A previous study reported that Fgf10 transcription begins to increase significantly starting from E15.5 (Al Alam et al., 2015) . (C) A cell membrane projection was imaged every 5 min for 45 min. The membrane projection (arrowhead) shows obvious changes between each imaging time point. (D) Lung explants were imaged in the presence of 100 nM CytoD, 40 mM CK666, 5 mM nocodazole, or 10 mM blebbistatin in the culture medium. The number of cell membrane projections per 1,000 mm of airway tube length was quantified (data are presented as mean ± SEM, n = 3 per treatment). N.S., not significantly different; **p < 0.01, Student's t test. Scale bars, 10 mm. See also Figure S3 and Movies S1, S2, S3, S4, and S5. Cells expressing FGF10 during embryonic lung development become lipofibroblasts in adult lungs, where they serve as the niche cells of adult alveolar stem cells (Barkauskas et al., 2013) . Our in situ experiments showed that Fgf10-expressing cells are broadly distributed in the distal lung mesenchyme at E16.5 and E18.5 ( Figure S4A ). All of these lines of evidence highlight that FGF10 functions in controlling the differentiation of alveolar progenitor cells. Fgf10 null mice, which die at birth, develop only rudimentary lung buds (Min et al., 1998) . Due to the absence of any appreciable lung structures in Fgf10 À/À embryos, it has been exceedingly difficult to characterize the function of FGF10 during late lung development.
To test the possibility that FGF10 may function as a chemotactic factor for alveolar progenitor cells, we analyzed the cell protrusion process by imaging E16.5 Fgf10 +/À lungs ( Figure 3A and Movie S6). The number of protruding cells decreased significantly in Fgf10 +/À lungs compared with wild-type lungs ( Figure 3B ). We also treated wild-type lung explants with PD0325901, a specific MEK1/2 inhibitor that can block FGF10/ FGFR2-mediated ERK1/2 signaling (Tang et al., 2011) . The number of protruding cells decreased significantly following PD0325901 treatment, a result similar to the phenotype that we had observed in Fgf10 +/À lung explants ( Figures 3A and 3B ; Movie S6). In addition, we compared the duration of the cell protrusion process in wild-type, Fgf10 +/À , and PD0325901-treated lung explants; the duration was quantified as the time from when a cell first showed a cell membrane projection until the whole cell body protruded out of the epithelium ( Figure 3A , control lung). In wild-type control lungs, the cell protrusion lasted between 2 and 4 hr ( Figure 3C ). However, in Fgf10 +/À and PD0325901-treated lungs, the protrusion process invariably required more than 4 hr ( Figure 3C ).
We developed a migration assay to determine whether the impaired epithelial cell protrusion of Fgf10 +/À lungs is specifically caused by a reduction in FGF10 dosage. Wild-type Id2 + epithelial cells of E16.5 lungs were plated in the upper well of a Transwell apparatus. Mesenchymal cells isolated either from Fgf10 +/À embryos or from their wild-type littermate embryos were prepared as previously reported (Lebeche et al., 1999) and were plated in the lower wells ( Figure 3D ). The migration of epithelial cells toward Fgf10 +/À mesenchymal cells was significantly impaired compared to the migration of epithelial cells toward wild-type mesenchymal cells and recombinant FGF10 ( Figures 3E and 3F) . Moreover, the migration of epithelial cells toward wild-type mesenchymal cells was significantly blocked by an FGF10-neutralizing antibody and by PD0325901 treatment ( Figures 3E and 3F ). There were no significant differences in the percentages of apoptotic Id2 + epithelial cells during or after the cell migration assay among all of the examined samples ( Figures  S4B and S4C ). Therefore, both our imaging analysis of Fgf10 +/À lung explants ( Figures 3A-3C ) and our migration assays ( Figures  3E and 3F ) support the conclusion that FGF10-mediated ERK1/2 signaling is essential for the alveolar progenitor cell protrusion process.
Protruded Cells Become AT2 Cells while Non-protruded Cells Become AT1 Cells Distal sac formation proceeds in a proximal-to-distal manner. The lumen opening and epithelial cell flattening has already occurred at the proximal part of airway tubules around E16.5. However, the distal airway lumen remains closed and epithelial cells in airway distal tips remain undifferentiated, continuing as alveolar progenitor cells Jain et al., 2015) . When we monitored the location of protruding cells at E16.5, both in live embryos and in lung explants, we found that all of the protruding cells were located close to distal airway tubule tips, where epithelial cell flattening has not occurred (n = 502, Figure 4A ). Additionally, these protruded epithelial cells express both an AT1 marker (Pdpn) and an AT2 marker (Prospc) (Figure 4B) . These results indicate that alveolar progenitor cells are able to protrude toward the mesenchyme prior to their differentiation, which immediately raises the question of how the cell fates of the protruded and non-protruded cells are specified. Importantly, we found there was only minimal opening of airway tubules in the imaged lung explants, and these tubules had very few flattened cells ( Figure 2A ); both of these phenotypes likely result from the lack of fetal breathing movements in lung explants.
To investigate the responses of protruded and non-protruded cells to fetal breathing movements, we connected a pump to E17 lung explants from Id2-CreER;Rosa26-mTmG mice (Figures 4C and S5A) . The Id2 + alveolar progenitor cells of the Id2-CreER; Rosa26-mTmG lung were labeled in a mosaic manner so that the cellular processes of individual cells could be monitored easily. At E17, many distal airway epithelial cells have already protruded from the airway epithelium, but the distal airway lumen remains closed (0 hr, Figure 4D ). To mimic fetal breathing movements, we pumped 8 mL of PBS alternately into and out of lung explants 6 times per minute ( Figure S5A and STAR Methods). Following 1 hr of such treatment, the airway lumen slowly began to open ( Figures 4D and 4E ) and many non-protruded cells started to flatten (n = 142, from 5 lung explants). After 5 hr, the A-C) Lungs collected from E16.5 wild-type mice (control), Fgf10 +/À mice, or E16.5 wild-type lungs treated with 100 nM PD0325901 were imaged for analysis of the epithelial cell protrusion process (A). White arrowheads indicate protruding cells with membrane projections. Compared with wild-type control lungs, the number of protruding cells decreased significantly in both Fgf10 +/À lungs and PD0325901-treated lungs (data are presented as mean ± SEM, n = 3) (B). In addition, in Fgf10 +/À lungs and PD0325901-treated lungs, the cell protrusion time was much longer than in the wild-type control lungs (data are presented as mean ± SEM, n = 3) (C). (D) Diagram to illustrate the Id2 + progenitor cell migration assay. Id2 + epithelial cells isolated from E16.5 wild-type lungs by FACS were plated in the upper well of a Transwell device. Recombinant FGF10, medium only, or mesenchymal cells isolated from E16.5 lungs were plated in the lower wells. (E and F) Id2 + progenitor cells that migrated toward the lower wells were stained with crystal violet (see STAR Methods). Fewer Id2 + progenitor cells migrated toward Fgf10 +/À mesenchymal cells than migrated toward wild-type mesenchymal cells. Treatments with an anti-FGF10 neutralizing antibody or PD0325901 impaired the migration of Id2 + progenitor cells toward wild-type mesenchymal cells (data are presented as mean ± SEM, n = 3). **p < 0.01, ***p < 0.001, ****p < 0.0001, Student's t test. Scale bars, 10 mm (A) and 2 mm (E). See also Figure S4 and Movie S6. (C-E) Pregnant females carrying Id2-CreER;Rosa26-mTmG embryos were treated with low-dose tamoxifen (TAM) at E15.5 for lineage labeling of a few Id2 + progenitor cells with a membrane GFP reporter. Imaged lung explants were collected from E17 Id2-CreER;Rosa26-mTmG embryos. At this stage, many Id2 + progenitor cells had finished the cell protrusion process (C). The trachea of the imaged lung explant was connected to a pump (see STAR Methods). The airway lumen (#) was closed before PBS was pumped into the lung explant. By 5 hr after the start of treatment, the airway lumen was clearly opened. The protruded cell (white arrowhead) maintained its cuboidal cell shape (D), whereas the non-protruded cell (white arrowhead) was gradually flattened (E). (F and G) Lung explants were stained with antibodies against GFP (green), Prospc (red), and Ager (white). Note that the protruded cell expresses Prospc but not Ager (F), whereas the non-protruded cell expresses Ager but not Prospc (G). Scale bars, 50 mm (A), 10 mm (B), and 10 mm (D-G). See also Figure S5 . airway tubules begun to appear as characteristic sac-like structures ( Figures 4D and 4E ). By the end of the imaging time course, none of the protruded epithelial cells had changed their cuboidal cell shape (n = 155, from 5 lung explants), whereas all of the nonprotruded cells were flattened and extended (Figures 4D, 4E , and S5B). Staining against Ager and Prospc showed that all of protruded cells were expressing Prospc but not Ager and that all of the flattened cells were expressing Ager but not Prospc (Figures 4F and 4G) . Moreover, immunofluorescent staining against ZO-1 (a marker of tight cell junctions) showed that the protruded cells maintain tight junctions with their neighboring non-protruded cells (Figures S5C and S5D ). No apoptotic cells were observed in treated lung explants ( Figure S5E) . These results reveal that protruded cells become cuboidal AT2 cells whereas non-protruded cells become flat AT1 cells.
The Cell Protrusion Process Functions to Ensure the AT2 Cell Fate Specification These observations led us to speculate that the cell protrusion process may prevent protruded cells from undergoing flattening. We hypothesized that inhibiting the cell protrusion process may cause more alveolar progenitor cells to undergo flattening, resulting in fewer AT2 cells. We showed earlier that CK666 treatment significantly inhibited the cell protrusion process in lung explants ( Figure 2D ). CK666 can specifically block the branching of polymerized actin filaments without interfering with the actin polymerization that is known to be induced by mechanical forces (Aragona et al., 2013) . The branched actin network can produce forces and push the plasma membrane at the leading edge of a cell, ultimately resulting in cell protrusion or other cell migration processes (Le Clainche and Carlier, 2008) . We treated pregnant females with CK666 (5 mg/kg or 10 mg/kg) via oral gavage once each day from E15.5 until embryos were analyzed at either E16.5 or E18.5. At E16.5, we confirmed that CK666 oral gavage treatments could significantly reduce the number of protruding cells at E16.5 in dose-dependent manner ( Figure S6A ). By E18.5, the CK666 treatment had significantly decreased the ratios of AT2 cells to AT1 cells ( Figures 5A-5D ), supporting our supposition that inhibiting the actin-based cell protrusion process impairs AT2 cell differentiation.
Having demonstrated that impaired cell protrusion leads to abnormal AT2 cell differentiation ( Figures 5A-5D ), the obvious next question was whether or not FGF10/FGFR2 signaling also controls the differentiation of AT2 cells. Given our result showing that FGF10 functions in the cell protrusion process ( Figures 3A-3C) , it is not surprising that the ratio of AT2 cells to AT1 cells decreased significantly in E18.5 Fgf10 +/À lungs compared with wild-type lungs ( Figures S6B-S6D ). This result is in agreement with the findings of a recent study (Chao et al., 2017) . Our immunostaining results of E17 lungs show higher expression of FGFR2 in protruded cells ( Figure S6E ). We therefore investigated the effect of deleting the Fgf10 receptor, Fgfr2, in Id2 + progenitor cells. Pregnant females that carried both Fgfr2 control and mutant embryos were treated with tamoxifen at E15. Embryos were sampled at E18.5 ( Figure 5E ). We found that loss of Fgfr2 in Id2 + progenitor cells significantly impaired their differentiation into AT2 cells ( Figures 5F-5H ). We also treated pregnant females with PD0325901 at E15.5 and analyzed the Id2 + progenitor cell differentiation in E18.5 embryos. As expected, the ratio of AT2 cells to AT1 cells decreased significantly in the lungs of PD0325901-treated embryos compared with vehicle-treated (control) embryos ( Figures  S6F-S6H) . These results together demonstrate that the differentiation of AT2 cells is controlled by signaling mediated by FGF10 and its receptor, FGFR2.
FGF10/FGFR2 signaling is essential for airway branching morphogenesis (Abler et al., 2009; Bellusci et al., 1997; Park et al., 1998) . We compared the number of branch tips of E18 Fgf10 +/À lungs or P00325901-treated lungs with that of control lungs ( Figure S7A ). Consistent with a previous study (Ramasamy et al., 2007) , the branching tip number of Fgf10 +/À lungs decreases slightly but shows no significant changes compared with wild-type littermate control lungs ( Figures S7A and S7B) ; furthermore, the PD0325901 treatment did not significantly change the number of branches ( Figures S7A and S7B ). We also quantified the branch tips of E18 lungs that were treated with either oligoamnios or the actin inhibitor, CK666. We saw no significant changes in the number of branching tips of treated lungs ( Figures S7A and S7B ). All of these results indicate that the observed impairment of alveolar epithelial cell differentiation does not result from any defect in airway branching morphogenesis.
Our finding that AT2 cell differentiation is significantly impaired in response to the inhibition of FGF10/FGFR2-mediated actinbased cell protrusion highlights the importance of the cell protrusion process in AT2 cell fate specification. We performed further fetal breathing movement experiments with E16.5 lung explants in which many cells had just started to protrude from the basal side of the airway epithelium but in which few cells had completely finished their cell protrusion process. Nearly all cells in distal buds were flattened, and were found to express Ager but not Prospc Figure 5 . The Cell Protrusion Process Ensures that Alveolar Progenitor Cells Differentiate into AT2 Cells (A-D) From E15.5, pregnant females were treated with 5 mg/kg (B) or 10 mg/kg (C) CK666 by oral gavage once a day for 3 days. Lungs were analyzed at E18.5 for immunostaining with antibodies against Ager (green), Pdpn (white), and Prospc (red). The ratio of AT2 cells to AT1 cells decreased significantly with CK666 treatments (D). In all examined E18.5 lungs, alveolar progenitor cells (i.e., those cells expressing markers of both AT1 cells and AT2 cells) accounted for fewer than 5% of alveolar epithelial cells. (E-H) Pregnant female mice carrying Id2-CreER;Fgfr2 F/+ ;Rosa26-mTmG (control) and Id2-CreER;Fgfr2 F/À ;Rosa26-mTmG (Fgfr2 mutant) embryos were treated with tamoxifen (TAM) at E15 (E). Lungs were analyzed at E18.5 for immunostaining with antibodies against GFP (green), Pdpn (white), and Prospc (red) (F and G). The ratio of AT2 cells to AT1 cells in all GFP + cells (cells in which CRE-mediated recombination had occurred) was quantified (data are presented as mean ± SEM, n = 3) (H). (I and J) Imaged lung explants were collected from E16.5 Shh-Cre;Rosa26-mTmG embryos. At this stage, many cells started to protrude but few cells had finished the cell protrusion process. When we performed fetal breathing movement experiments on these lung explants, in which no protruded cells were observedin distal airway tubule tips, all cells in distal buds were flattened (n = 4 lungs; # denotes airway lumen) (I). Treated Shh-Cre;Rosa26-mTmG lung explants were stained with antibodies against GFP (green), Ager (white), and Prospc (red) (J). **p < 0.01; ***p < 0.001; Student's t test. Scale bars, 50 mm (A-C, F, G, and J) and 10 mm (I). See also Figures S6 and S7. ( Figures 5I and 5J) , demonstrating the essential role of cell protrusion in AT2 cell fate specification. Together, these results support our conclusion that the FGF10/FGFR2-mediated actin-based cell protrusion process ensures the AT2 cell fate specification.
Enrichment of Myosin at the Apical Region of Protruded Alveolar Progenitor Cells It was highly conspicuous at E17 that the apical surface of AT2 cells appeared to be much smaller than the apical surfaces of AT1 cells (Figures 4F and 4G) . We tentatively propose that when inhaled amniotic fluid reaches distal airways and thereby exerts mechanical forces on the distal airway epithelium, the smaller apical surface area of the protruded cells may somehow facilitate their embedment in the mesenchyme, perhaps thereby preventing these cells from being flattened by mechanical forces.
To determine whether the reduction in the apical surface area of AT2 cells results from the actin-based cell protrusion process, we labeled Id2 + progenitor cells of Id2-CreER;Rosa26-mTmG lungs in a mosaic manner ( Figure 6A ). Before the cell protrusion process started, the apical surface area of the protruded cells showed no significant difference compared with the apical surface area of non-protruded cells ( Figure 6B ). However, once the membrane projection appeared, the apical surface area of the protruding cells quickly decreased in area ( Figure 6C ). The final surface area of the protruded cells was less than 20% of their initial surface area ( Figure 6C) . Conversely, the surface area of neighboring non-protruding cells remained either unchanged or increased slightly ( Figure 6D) . Therefore, the surface of apical region shrinks during the cell protrusion process. It is known that cell shrinks its trailing edge during cell migration and protrusion, and the rear of cell body contains enriched myosin. We found that phosphomyosin light chain II is highly enriched at the apical region of protruded cells of E17 lungs (Figure 6E) . Therefore, the cell protrusion process leads to the apical myosin enrichment in protruded cells.
Apical Myosin Functions to Prevent Alveolar Progenitor Cells from Being Flattened
The phosphorylation of the myosin light chain II promotes the myosin to bind to the actin filaments and then generates contractile forces by pulling actin filaments. This leads us to propose that the increased apical accumulation of phosphomyosin light chain II protein may function to prevent flattening by the mechanical forces generated from inhaled amniotic fluid. We treated E17 lung explants with the myosin inhibitor blebbistatin (10 mM) and performed artificial fetal breathing movements. In control lungs, all protruded cells maintained their cuboidal cell shape and became AT2 cells. Following blebbistatin treatment, many protruded cells gradually became flattened (Figures 7A and 7B ) and 20% of protruded cells exhibited AT1 cell fate (expressing Ager but not Prospc) ( Figures 7C and 7D) . These results demonstrate that an accumulated contractile myosin structure in the apical region of protruded cells functions to prevent protruded cells from being flattened by mechanical forces.
DISCUSSION
Decades of studies have established how localized growth factors contribute to organ development and cell differentiation, and multiple recently published studies have demonstrated that mechanical stimuli control the differentiation of stem cells and progenitor cells, often independently of any signals from growth factors (Aguilar et al., 2016; Cohen and Chen, 2008; Cozzolino et al., 2016; Gilbert et al., 2010; Huang et al., 2012; Wen et al., 2014) . Genetic studies have provided insight into how either growth factors or mechanical forces regulate cell differentiation, but very little is known about how stem cells/progenitor cells respond synergistically to regulatory signals imparted by these disparate inputs. The live imaging techniques that we developed here allowed us to monitor individual alveolar progenitor cells and to characterize their responses to both mechanical forces and growth factors.
We here establish that both an actin-based cell protrusion process and a mechanical force-induced cell flattening process have essential functions in controlling alveolar epithelial cell differentiation. These two cellular processes occur at different developmental stages. At E16.5, an actin-dependent cell protrusion process allows protruding alveolar progenitor cells to embed their body in the mesenchyme, thereby shrinking their trailing edge (i.e., the apical side of protruding cells), and accumulate abundant myosin in their apical region. Lacking this cell protrusion process, the non-protruded cells are not able to accumulate myosin in their apical region. At a later stage (E17), when inhaled amniotic fluid reaches the distal airways and exerts mechanical forces on the airway epithelium, the mechanical forces generated by fetal breathing movements promote the flattening of the non-protruded alveolar progenitor cells; these cells later differentiate into AT1 cells.
The apical enriched myosin of protruded cells therefore provides structural support to help withstand the mechanical forces and thus promote maintenance of their cuboidal cell shape ( Figure 7E ). Similar to our finding that the majority of the cell body of AT2 cells in E18.5 lungs is located beneath the alveolar surface ( Figure S1D ), AT2 cells in adult lungs also have limited apical surface area facing the alveolar epithelium (Sirianni et al., 2003) . Viewed in the context of our discovery about the role of the cell protrusion process in withstanding mechanical forces, it seems very likely that the AT2 cells in adult lungs are also better able to withstand mechanical forces than are AT1 cells.
Our migration assay result shows that both recombinant FGF10 and mesenchymal cells can induce the migration of Id2 + progenitor cells, suggesting that FGF10 serves as a local chemotactic factor to induce an actin-based cell protrusion process of alveolar progenitor cells at E16.5. A previous study reported that localized FGF10 is not required for branching morphogenesis (during epithelial bud outgrowth) in an Fgf10 ubiquitous overexpression mouse model (Volckaert et al., 2013) . However, the effect of ubiquitously overexpressing Fgf10 on branching morphogenesis and alveolar epithelial cell differentiation requires further investigation since these lungs show an abnormal branching pattern and impaired proximaldistal epithelial differentiation after E13.5. Given the fact that the expression level of FGF10 at the alveolar saccular stage (after E15.5) is much higher than the expression level of FGF10 at the early branching morphogenesis stage (from E11.5 to E14.5) (Al Alam et al., 2015) , we now speculate that the different observed effects of FGF10 on cellular behavior may actually result from differential expression levels of FGF10. Considering this, one possible explanation for the increased number of AT2 cells in the lungs treated with oligoamnios is that more alveolar progenitor cells may be able to protrude toward FGF10 in the mesen-chyme if the cell flattening process is delayed by the reduction of mechanical forces.
In agreement with a previous finding (Rawlins et al., 2009 ), Id2 + cells are located at the airway tips and express both Pdpn and Pregnant females that carried Id2-CreER;Rosa26-mTmG embryos were treated with tamoxifen at E15.5 and lungs were imaged at E16.5 (A). The initial apical surface area was not different between protruded and non-protruded cells (B; data are presented as mean ± SEM). Once the protruding process started (0:00), the apical surface area of the protruded cells (arrowhead) decreased rapidly (A and C, n = 6); this decrease did not occur in non-protruded cells (A and D, n = 7). (E) Lungs collected from E17 Shh-CreER;Rosa26-mTmG embryos were immunostained with antibodies against GFP (green) and phosphomyosin light chain II (red). The two protruded cells express high levels of phosphomyosin light chain II protein at their apical regions. N.S., not significantly different, Student's t test. Scale bars, 10 mm (A and E).
Prospc (Figures S2G and S2H) . The lineage-tracing experiment has demonstrated that some individual Id2 + cells in the early airway tips (E11.5) are multipotent and can give rise to both airway and alveolar epithelial cells (Rawlins et al., 2009 ). After E16.5, Id2 + tip cells only give rise to alveolar epithelial cells. Recent studies using single-cell RNA-sequencing analysis and lineage-tracing experiments have shown that alveolar progenitor cells contain heterogeneous populations Rashid et al., 2017; Treutlein et al., 2014) . In addition, single-cell RNA-sequencing analyses have suggested different cell lineage models of alveolar epithelial cell differentiation (Rashid et al., 2017; Treutlein et al., 2014) . Therefore, it remains unclear whether Id2 + alveolar progenitor cells represent the same cell population as the recently identified bipotent progenitor cells . Future investigations with additional single-cell lineage-tracing experiments and single-cell RNAsequencing analysis will be able to compare the cell identity of Id2 + alveolar progenitor cells (Rawlins et al., 2009 ) and the bipotent progenitors , and further refine our understanding of the cellular and molecular mechanisms underlying alveolar progenitor cell differentiation. Our findings demonstrate a sophisticated developmental program that is controlled by both mechanical forces and growth factor-mediated signaling. Other recent studies have shown that both mechanical forces and growth factors are required for lung post-injury repair (Chao et al., 2017; Liu et al., 2016) . In addition to the lung, many other organs (heart, muscles, etc.) have their unique mechanical properties and contexts and are constantly exposed to ever-present mechanical forces. Our study highlights the essential need to consider the coordinated influences of both mechanical forces and growth factors to obtain a comprehensive and thus accurate understanding of the development and regeneration of such organs. Insights gained from studies that account for these multiple regulatory influences will very likely lead to important breakthroughs in our ability to successfully engineer tissues and organs in the future.
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Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Nan Tang (tangnan@nibs.ac.cn) .
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Shh-Cre (Harfe et al., 2004) , Id2-CreER (Rawlins et al., 2009) , Rosa26-LNL-tTA (Rosa26-tTA) (Wang et al., 2008 ), tetO-H2BGFP (Tumbar et al., 2004 , Rosa26-CAG-mTmG (Rosa26-mTmG) (Muzumdar et al., 2007) , Fgf10 +/- (Min et al., 1998) , and Fgfr2 flox/flox (Yu et al., 2003) mice have been described previously. Noon of the day on which a vaginal plug was detected was considered E0.5. FVBN mice were used for the inhibitor and oligoamnios treatment experiments. All experiments were approved by the Institutional Review Board at the National Institute of Biological Science, Beijing (NIBS), and were performed in accordance with the recommendations in the NIBS Guide for Care and Use of Laboratory Animals.
METHOD DETAILS
In Vivo Embryonic Lung Live Imaging System
We set up an in vivo live imaging system by adapting the imaging method in a previous study (Looney et al., 2011) . The pregnant female was given 15 ml/g sodium phenobarbital (0.8% in saline) by intraperitoneal injection. The uterus was exposed after an incision along the medioventral line was made. The experimental embryo in utero was pulled into the incubation dish and embedded into 3% low melting agarose (Lonza). Small incisions were made first on the uterus and then on the chest wall of the embryo to expose the lung. During the image capture operation, 10 mm Hg negative pressure was administrated through a vacuum regulator (Amvex) to hold the lung. The incubation dish was filled with circulating warm PBS to maintain the embryo body temperature. All imaging pictures were taken with a two-photon microscope (Olympus) with a 25x water lens.
Embryonic Lung Explant Imaging System
Embryos at different developmental stages were dissected and transferred to a 60 mm dish coated with silica gel. Four limbs of embryos were stabilized to the silica gel using needles. Ribs and the sternum were carefully removed to expose the heart and lung. A 30 gauge needle was inserted into the right ventricle of the heart. DMEM/F12 medium supplemented with 30% FBS and 1 U/ml penicillin-streptomycin (Thermo Scientific) was pumped (BT100-2J, Longer) into the heart at a speed ranging from 50 ml/minute to 100 ml/minute. Before the imaging experiment, the embryo body was embedded in 2% low melting agarose (Lonza).
Administration of Inhibitors in Lung Explant Live Imaging Experiments
For the treatment of lung explants with PD0325901, 5 mg/g PD0325901 (Sigma) was administrated to pregnant females via oral gavage 12 hours before the experiment. During the live imaging experiment, 100 nM PD0325901 was added into the DMEM/F12 
Fetal Breathing Movements in Lung Explants
In order to mimic fetal breathing movements, a 30 gauge needle was inserted into the trachea and PBS was pumped into and out of the trachea by a pump (BT100-2J, Longer) at a speed of 6-8 ml/ 10 seconds (each time). The frequency of these fetal breathing movements was 6 times/minute.
Imaging and Characterization of Id2 + Lineage Labeled Progenitor Cells in the Lung Explants Treated with Artificial Fetal Breathing Movements Pregnant females carrying Id2-CreER; Rosa26-mTmG embryos were injected with a low dosage (50 mg/g) of tamoxifen at E15. We used a low dose with the intent of labeling relatively few Id2 + cells; and indeed, we typically found that fewer than 3 Id2 + progenitor cells were lineage labeled in a single distal tubule. In a few cases, two adjacent progenitor cells were lineage labeled because the cell division of the labeled progenitor cell generated two daughter cells. Lungs were collected from Id2-CreER; Rosa26-mTmG embryos at E17 and were connected to a pump to mimic fetal breathing movements. After imaging, lungs were fixed with 4% PFA. 20 mm frozen sections of the lungs were stained with antibodies against GFP, Prospc, and Ager.
Aspiration of Amniotic Fluid or Injection of FITC-Labeled Microspheres into Amniotic Fluid
A small incision was made on the abdominal wall of an anaesthetized pregnant female. The embryos were slowly pulled out with a cotton swab. A majority of the amniotic fluid was then aspirated using a syringe with a 28 gauge needle. The incision was sutured after all embryos were placed back into the female's abdominal cavity. Because the needle hole causes a mild leakage of amniotic fluids, we used non-treated littermates as controls. To inject FITC-labeled microspheres, 50 ml Fluosphere (1:50 in saline, F8472, Invitrogen) was injected into the amniotic fluid. Lungs were analyzed 24 hours after the Fluosphere injection.
Administration of PD0325901 and CK666 to Pregnant Females
The pregnant females were treated with PD0325901 (5 mg/g, Sigma) or CK666 (5 mg/kg or 10 mg/kg, Sigma) by oral gavage from E15.5 once a day for three days, and embryonic lungs were sampled at E18.5.
Isolating Id2 + Progenitor Cells and Mesenchymal Cells from E16.5 Lungs The Id2-CreER; Rosa 26-mTmG mice were injected tamoxifen (120 mg/g) at E15.5. E16.5 lungs from Id2-CreER; Rosa 26-mTmG embryos were enzymatically digested for isolating the mesenchymal cells and Id2 + progenitor cells. The procedures of mesenchymal cell isolation have been described previously (Lebeche et al., 1999) . Briefly, after removing the heart and trachea, E16.5 lungs were cut into 1 mm 3 pieces. Lung tissues were digested using a neutral protease (Worthington Biochemical Corporation) and DNase I (Roche) at 37 C for 20 minutes. The enzymatic reaction was stopped by the addition of DMEM with 10% FBS. The tissue suspension was passed through a 100 mm mesh filter (Thermo Scientific) to remove undigested tissue fragments. After spinning down the tissue suspension, the cell pellet was resuspended in a RBC lysis buffer (BD Biosciences) and then passed through a 40 mm mesh filter (Thermo Scientific). Cells were resuspended by DMEM/F12 with 10% FBS and cultured in a 35 mm dish for 1.5 hours. The adherent cells (enriched mesenchymal cells) were trypsinized. Cell number was quantified by a hemocytometer. The supernatant was centrifuged at 300g for 10 minutes and resuspended in sorting buffer (PBS supplemented with 0.05% BSA and 2 mM EDTA). Then GFP + cells were then sorted via flow cytometry (Aria II, BD Biosciences).
Migration Assay
Freshly isolated Id2 + epithelial cells (5 x10 4 ) were resuspended in 200 ml medium containing 1% FBS and seeded into the upper wells of Transwell devices (6.5 mm diameter, 8 mm pore size, Corning Costar). The upper wells were precoated with 10 mg/ml fibronectin (Invitrogen) for 3 hours at 37 C. Mesenchymal cells (1 x10 5 ) were resuspended in 600 ml of serum-free medium and seeded in the lower wells of the Transwell device. For the positive control, 200 ng/ml recombinant FGF10 in 600 ml of serum-free medium was added in the lower wells of the Transwell device. For the negative control, only 600 ml of serum-free medium was added in the lower wells of the Transwell device. Cells were then cultured at 37 C for 48 hours. After removing non-migrated cells that stayed inside of the upper wells with a cotton swab, migrated cells on the outside of the upper well membrane were fixed with 4% PFA and stained with a 0.09% crystal violet solution (Sigma). The cell-stained crystal violet was washed with 200 ml 10% acetic acid. The amount of crystal violet was quantified by measuring absorbance at 540 nm (A). 20 ng/ml FGF10 neutralizing antibody (sc7375, Santa Cruz) and 20 ng/ml IgG control (sc2028, Santa Cruz) were added to the lower wells. 500 nM PD0325901 (Sigma) was added to the lower wells. For analyzing apoptotic cells during and after the migration assay, Id2 + epithelial cells on transwells were gently washed with PBS and then fixed with 4% PFA at 24 hours or 48 hours post-seeding. Cells were then stained with an antibody against cleaved Caspase-3.
Culturing Id2 + Epithelial Cells on Silicone Membranes of an Equibiaxial Strain Cell Culture System or on Polyacrylamide Gels The equibiaxial strain system used for Id2 + progenitor cell stretching assay was described in a previous study (Liu et al., 2016) . Briefly, first assemble a customer-made cylinder holder, an indenter ring, and an Oring with a piece of silicone membrane so that the silicone QUANTIFICATION AND STATISTICAL ANALYSIS Quantifying the Number of Branch Tips of E18 Lungs Left lung lobes of E18 lungs were stained in wholemount with antibodies against E-cadherin (1:250, 13-1900, Invitrogen) and smooth muscle actin (1:250. C6198, Sigma), as previously described (Tang et al., 2011) . The number of branch tips was quantified as previously described (Alanis et al., 2014) . Only the branch tips (from L.L1 to L.L6) that were only close to the flat edge of left lobe were quantified. At least three lungs were quantified for each group.
Quantification of Apical Surface Area of Protruding Cells
To quantify the apical surface area of mGFP lineage labeled cells, we used the ''Surface'' function of Imaris software. We first built the 3D shape of the membrane GFP labeled cells and surrounding membrane Td-tomato labeled cells. Then the apical surface area can be recognized and quantified by the Imaris software. Apical surface areas were quantified with the Imaris program (Bitplane).
Quantification of the Distance between Two AT1 Cells
The distance between the nuclei of neighboring AT1 cells were quantified using the 'freehand selection' tool in ImageJ software .
Quantification of the Tubular Length
The tubular length was quantified using the 'freehand selection' tool in ImageJ software.
Quantification of the Cell Aspect Ratio Change
The aspect ratio changes were quantified following the quantification of ''shape volatility'' described in a previous study . The cell shape was outlined using the 'freehand selection' tool in ImageJ software to mark the cell membrane to get the region of interest (ROI). Then each ROI was analyzed by using the 'Fit Ellipse' and 'Measure' function to determine the aspect ratio. Mathematically, the aspect ratio change is calculated as DAR=AR time 5:00 /AR time0:00 .
Statistical Analysis
All data are presented as mean ± s.e.m. (as indicated in figure legends). The data presented in the figures were collected from multiple independent experiments performed on different days using different mice. Unless otherwise mentioned, most of the data presented in figure panels are based on at least three independent experiments. The inferential statistical significance of differences between sample means was evaluated using two-tailed unpaired Student's t-tests.
